Form 10-Q · Quarterly report
Palantir Technologies 10-Q, filed Nov 3, 2026
- Filed
- CIK
- 0001321655
- Accession no.
- 0001321655-26-000048
Summary
Palantir Technologies generated $2.3 billion in revenue in the three months ended September 30, 2026, up 96% from $1.2 billion a year earlier, with income from operations of $1.1 billion and gross profit of $1.9 billion at an 83% margin. Customer count rose to 1,090 from 911, and the company said U.S. customers accounted for 81% of revenue in the first nine months of 2026.
Key points
- Revenue for the nine months ended September 30, 2026 was $5.9 billion, a 92% increase from $3.1 billion a year earlier.
- Quarterly income from operations was $1.1 billion, or $1.4 billion on an adjusted basis excluding stock-based compensation and related employer payroll taxes.
- The top twenty customers averaged $146 million in trailing-twelve-month revenue, up 76% from $83 million a year earlier.
- In the nine months ended September 30, 2026, 51% of revenue came from government customers, 49% from commercial customers, and 81% from customers in the United States.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Overview We build software that empowers organizations to effectively integrate their data, decisions, and operations at scale. We were founded in 2003 and started building software for the intelligence community in the United States to assist in counterterrorism investigations and operations. We later began working with commercial enterprises, who often faced fundamentally similar challenges in working with data. We have built four principal software platforms, Gotham, Foundry, Apollo, and our Artificial Intelligence Platform (“AIP”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.